Clinical efficacy of tibial transverse transport with debridement for the treatment of 31 patients with necrotizing fasciitis of the lower extremities.
10.12200/j.issn.1003-0034.20241220
- Author:
Da-Peng YU
1
;
Xiao-Chong ZOU
1
;
Xu-Bo LONG
1
;
Xin-Yu NIE
2
;
Qi-Kai HUA
1
Author Information
1. Department of Orthopaedic, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China.
2. Department of Orthopaedic, the First Affiliated Hospital of USTC, Anhui Provincial Hospital, Hefei 230001, Anhui, China.
- Publication Type:Journal Article
- Keywords:
Debridement;
Lower limb necrotizing fasciitis;
Tibial transverse transport
- MeSH:
Humans;
Male;
Female;
Middle Aged;
Aged;
Adult;
Fasciitis, Necrotizing/mortality*;
Retrospective Studies;
Debridement;
Lower Extremity/surgery*;
Tibia/surgery*
- From:
China Journal of Orthopaedics and Traumatology
2025;38(9):945-950
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore clinical efficacy of tibial transverse transport (TTT) combined with debridement in treating necrotizing fasciitis of the lower extremities.
METHODS:A retrospective analysis was conducted on 31 patients with necrotizing fasciitis of the lower extremities who were treated with TTT from January 2021 to October 2023, including 28 males and 3 females, aged from 44 to 76 years old with an average of (57.58±8.79) years old. In-hospital mortality rate, amputation rate, length of hospital stay, hospitalization cost, number of surgeries, and inflammatory indicators before and after operation (white blood cells, hemoglobin, C-reactive protein, albumin), as well as wound healing and daily living ability were observed and compared.
RESULTS:All 31 patients were followed up for 3 to 12 months with an average of (6.61±2.46) months. All patients' wounds healed without recurrence. The wound healing time was (4.96±2.61) months, amputation rate of 31 patients was 3.22% (1/31), in-hospital mortality rate was 0%, the length of hospital stay was (27.10±24.51) days, the hospitalization cost was (107, 300 ± 83, 300) yuan, and the number of surgeries was (3.26±1.93) times. White blood cells, C-reactive protein and albumin before operation were (13.41±5.54) ×109/L, (136.67±73.50) mg·L-1 and (25.92±5.59) g·L-11 respectively, and improved to (11.05±3.65) ×109/L, (79.91±51.40) mg·L-1, and (30.31±4.02) g·L-1 at 2 weeks after operation, and the differences were statistically significant (P<0.05);there was no statistically significant difference in hemoglobin before and after operation (P>0.05). At the latest follow-up, 16 patients were able to take care of themselves, 12 patients were partially self-sufficient, and 3 patients were completely unable to take care of themselves.
CONCLUSION:TTT with debridement could achieve satisfactory clinical efficacy in treating necrotizing fasciitis of the lower extremities.
